Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats

Cardiovascular Research

Volumn 65, Issue 4, 2005, Pages 921-929

  Tsuruda, Toshihiro ^a,b   Kato, Johji ^a   Hatakeyama, Kinta ^a   Masuyama, Hiroyuki ^a   Cao, Yuan Ning ^a   Imamura, Takuroh ^a   Kitamura, Kazuo ^a   Asada, Yujiro ^a   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b MINAMI KYUSHU UNIVERSITY   (Japan)

Author keywords

Extracellular matrix; Fibrosis; Hypertension; Peptide hormone; Remodeling

Indexed keywords

8 BROMO CYCLIC AMP; ADRENOMEDULLIN; ALPHA SMOOTH MUSCLE ACTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; KI 67 ANTIGEN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; TRANSFORMING GROWTH FACTOR BETA1;

ADVENTITIA; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; FIBROBLAST; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HYPERTENSION; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REDUCTION; SYSTOLIC BLOOD PRESSURE;

ACTINS; ADRENOMEDULLIN; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CARDIOTONIC AGENTS; CELL DIFFERENTIATION; CELL DIVISION; CELL SIZE; COLLAGEN TYPE I; CONNECTIVE TISSUE; FIBROBLASTS; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; MYOCYTES, CARDIAC; PEPTIDES; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR REMODELING;

EID: 13844276700     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.11.004     Document Type: Article

References (34)

1. K.T. Weber Targeting pathological remodeling: concepts of cardioprotection and reparation Circulation 102 2000 1342 1345
2. A. Nicoletti, and J.B. Michel Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors Cardiovasc. Res. 41 1999 532 543
3. D.W. Powell, R.C. Mifflin, J.D. Valentich, S.E. Crowe, J.I. Saada, and A.B. West Myofibroblasts: I. Paracrine cells important in health and disease Am. J. Physiol. 277 Cell Physiol 46 1999 C1 C9
4. Y. Shi, J.E. O'Brien Jr., A. Fard, and A. Zalewski Transforming growth factor-β1 expression and myofibroblast formation during arterial repair Arterioscler. Thromb. Vasc. Biol. 16 1996 1298 1305
5. S.E. Campbell, and L.C. Katwa Angiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts J. Mol. Cell. Cardiol. 29 1997 1947 1958
6. P.E. McEwan, G.A. Gray, L. Sherry, D.J. Webb, and C.J. Kenyon Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo Circulation 98 1998 2765 2773
7. S.E. Campbell, J.S. Janicki, and K.T. Weber Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone J. Mol. Cell. Cardiol. 27 1995 1545 1560
8. P.J. Lijnen, V.V. Petrov, and R.H. Fagard Association between transforming growth factor-β and hypertension Am. J. Hypertens. 16 2003 604 611
9. J.N. Wilcox, E.I. Okamoto, K.I. Nakahara, and J. Vinten-Johansen Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors? Ann. N. Y. Acad. Sci. 947 2001 68 90
10. F. Kuwahara, H. Kai, K. Tokuda, M. Kai, A. Takeshita, and K. Egashira Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats Circulation 106 2002 130 135
11. K. Kitamura, K. Kangawa, M. Kawamoto, Y. Ichiki, S. Nakamura, and H. Matsuo Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma Biochem. Biophys. Res. Commun. 192 1993 553 560
12. K. Kitamura, K. Kangawa, and T. Eto Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions Microsc. Res. Tech. 57 2002 3 13
13. T. Tsuruda, J. Kato, K. Kitamura, M. Kawamoto, K. Kuwasako, and T. Imamura An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth Cardiovasc. Res. 43 1999 958 967
14. T. Horio, T. Nishikimi, F. Yoshihara, H. Matsuo, S. Takishita, and K. Kangawa Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts Eur. J. Pharmacol. 382 1999 1 9
15. R. Nakamura, J. Kato, K. Kitamura, H. Onitsuka, T. Imamura, and Y. Cao Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats Circulation 110 2004 426 431
16. T. Tsuruda, M. Jougasaki, G. Boerrigter, L.C. Costello-Boerrigter, A. Cataliotti, and S.C. Lee Ventricular adrenomedullin is associated with myocyte hypertrophy in human transplanted heart Regul. Pept. 112 2003 161 166
17. T. Tsuruda, J. Kato, K. Kitamura, T. Imamura, Y. Koiwaya, and K. Kangawa Enhanced adrenomedullin production by mechanical stretching in cultured rat cardiomyocytes Hypertension 35 2000 1210 1214
18. T. Ota, T. Takamura, H. Ando, E. Nohara, H. Yamashita, and K. Kobayashi Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model Diabetologia 46 2003 843 851
19. N. Nishikawa, K. Yamamoto, Y. Sakata, T. Mano, J. Yoshida, and T. Miwa Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation Cardiovasc. Res. 57 2003 766 774
20. D. Proudnikov, V. Yuferov, Y. Zhou, K.S. LaForge, A. Ho, and M.J. Kreek Optimizing primer-probe design for fluorescent PCR J. Neurosci. Methods 123 2003 31 45
21. T. Tsuruda, G. Boerrigter, B.K. Huntley, J.A. Noser, A. Cataliotti, and L.C. Costello-Boerrigter Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases Circ. Res. 91 2002 1127 1134
22. R. Zak Cell proliferation during cardiac growth Am. J. Cardiol. 31 1973 211 219
23. Y. Tomoda, K. Kikumoto, Y. Isumi, T. Katafuchi, A. Tanaka, and K. Kangawa Cardiac fibroblasts are major production and target cells of adrenomedullin in the heart in vitro Cardiovasc. Res. 49 2001 721 730
24. B.S. Burlew, and K.T. Weber Connective tissue and the heart. Functional significance and regulatory mechanisms Cardiol. Clin. 18 2000 435 442
25. M.O. Gray, C.S. Long, J.E. Kalinyak, H.T. Li, and J.S. Karliner Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-β1 and endothelin-1 from fibroblasts Cardiovasc. Res. 40 1998 352 363
26. M. Harada, Y. Saito, O. Nakagawa, Y. Miyamoto, M. Ishikawa, and K. Kuwahara Role of cardiac nonmyocytes in cyclic mechanical stretch-induced myocyte hypertrophy Heart Vessels 12 1997 198 200
27. S. Jesmin, I. Sakuma, Y. Hattori, and A. Kitabatake Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats Arterioscler. Thromb. Vasc. Biol. 23 2003 2021 2026
28. L.M. Montuenga, J.M. Mariano, M.A. Prentice, F. Cuttitta, and S.B. Jakowlew Coordinate expression of transforming growth factor-β1 and adrenomedullin in rodent embryogenesis Endocrinology 139 1998 3946 3957
29. K. von der Hardt, M.A. Kandler, K. Popp, E. Schoof, M. Chada, and W. Rascher Aerosolized adrenomedullin suppresses pulmonary transforming growth factor-β1 and interleukin-1β gene expression in vivo Eur. J. Pharmacol. 457 2002 71 76
30. 2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation Am. J. Respir. Cell Mol. Biol. 29 2003 537 544
31. A. Mallat, A.M. Préaux, C. Serradeil-Le Gal, D. Raufaste, C. Gallois, and D.A. Brenner Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate- mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors J. Clin. Invest. 98 1996 2771 2778
32. P. Niu, T. Shindo, H. Iwata, S. Iimuro, N. Takeda, and Y. Zhang Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage Circulation 109 2004 1789 1794
33. T. Shimosawa, Y. Shibagaki, K. Ishibashi, K. Kitamura, K. Kangawa, and S. Kato Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage Circulation 105 2002 106 111
34. J. Kawai, K. Ando, A. Tojo, T. Shimosawa, K. Takahashi, and M.L. Onozato Endogenous adrenomedullin protects against vascular response to injury in mice Circulation 109 2004 1147 1153